| Secukinumab in plaque psoriasis—results of two phase 3 trials RG Langley, BE Elewski, M Lebwohl, K Reich, CEM Griffiths, K Papp, ... New England Journal of Medicine 371 (4), 326-338, 2014 | 2228 | 2014 |
| Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo … CL Leonardi, AB Kimball, KA Papp, N Yeilding, C Guzzo, Y Wang, S Li, ... The Lancet 371 (9625), 1665-1674, 2008 | 1961 | 2008 |
| Glycoprotein-D–adjuvant vaccine to prevent genital herpes LR Stanberry, SL Spruance, AL Cunningham, DI Bernstein, A Mindel, ... New England Journal of Medicine 347 (21), 1652-1661, 2002 | 984 | 2002 |
| Once-daily valacyclovir to reduce the risk of transmission of genital herpes L Corey, A Wald, R Patel, SL Sacks, SK Tyring, T Warren, JM Douglas Jr, ... New England Journal of Medicine 350 (1), 11-20, 2004 | 945 | 2004 |
| A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction KA Papp, S Tyring, M Lahfa, J Prinz, CEM Griffiths, AM Nakanishi, R Zitnik, ... British Journal of Dermatology 152 (6), 1304-1312, 2005 | 862 | 2005 |
| A novel targeted T-cell modulator, efalizumab, for plaque psoriasis M Lebwohl, SK Tyring, TK Hamilton, D Toth, S Glazer, NH Tawfik, ... New England Journal of Medicine 349 (21), 2004-2013, 2003 | 719 | 2003 |
| Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia: a randomized, double-blind, placebo-controlled trial S Tyring, RA Barbarash, JE Nahlik, A Cunningham, J Marley, M Heng, ... Annals of Internal Medicine 123 (2), 89-96, 1995 | 689 | 1995 |
| Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials L Corey, AGM Langenberg, R Ashley, RE Sekulovich, AE Izu, ... Jama 282 (4), 331-340, 1999 | 586 | 1999 |
| Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years. B Romanowski, PC de Borba, PS Naud, CM Roteli-Martins, ... Lancet (London, England) 374 (9706), 1975-1985, 2009 | 382 | 2009 |
| Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study M Reitano, S Tyring, W Lang, C Thoming, AM Worm, S Borelli, ... Journal of Infectious Diseases 178 (3), 603-610, 1998 | 291 | 1998 |
| A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis SL Spruance, SK Tyring, B DeGregorio, C Miller, K Beutner Archives of internal medicine 156 (15), 1729-1735, 1996 | 232 | 1996 |
| A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections SK Tyring, JM Douglas Jr, L Corey, SL Spruance, J Esmann, ... Archives of dermatology 134 (2), 185-191, 1998 | 164 | 1998 |
| Famciclovir for ophthalmic zoster: a randomised aciclovir controlled study S Tyring, R Engst, C Corriveau, N Robillard, S Trottier, S Van Slycken, ... British journal of ophthalmology 85 (5), 576-581, 2001 | 136 | 2001 |
| Kaposi's sarcoma and other manifestations of human herpesvirus 8 P Geraminejad, O Memar, I Aronson, PL Rady, U Hengge, SK Tyring Journal of the American Academy of Dermatology 47 (5), 641-655, 2002 | 134 | 2002 |
| A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized … A Blauvelt, K Papp, A Gottlieb, A Jarell, K Reich, C Maari, KB Gordon, ... British journal of dermatology 182 (6), 1348-1358, 2020 | 129 | 2020 |
| Safety and immunogenicity of glycoprotein D—adjuvant genital herpes vaccine DI Bernstein, FY Aoki, SK Tyring, LR Stanberry, CS Pierre, SD Shafran, ... Clinical infectious diseases 40 (9), 1271-1281, 2005 | 105 | 2005 |
| A randomized, double-blind trial of famciclovir versus acyclovir for the treatment of localized dermatomal herpes zoster in immunocompromised patients S Tyring, R Belanger, W Bezwoda, P Ljungman, R Boon, RL Saltzman Cancer investigation 19 (1), 13-22, 2001 | 97 | 2001 |
| Human herpesvirus 8 DNA sequences in blistering skin from patients with pemphigus OM Memar, PL Rady, RM Goldblum, A Yen, SK Tyring Archives of dermatology 133 (10), 1247-1251, 1997 | 96 | 1997 |
| Human herpesvirus-8: detection of novel herpesvirus-like DNA sequences in Kaposi's sarcoma and other lesions OM Memar, PL Rady, SK Tyring Journal of molecular medicine 73, 603-609, 1995 | 79 | 1995 |
| Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: results from a randomized, controlled clinical trial JW Gnann Jr, CS Crumpacker, JP Lalezari, JA Smith, SK Tyring, KF Baum, ... Antimicrobial agents and chemotherapy 42 (5), 1139-1145, 1998 | 77 | 1998 |
Jouni UittoThomas Jefferson UniversityVerified email at jefferson.edu
